Literature DB >> 22492220

Luteal phase GnRHa trigger in random start fertility preservation cycles.

Enis Ozkaya1, Gabriel San Roman, Kutluk Oktay.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22492220      PMCID: PMC3370040          DOI: 10.1007/s10815-012-9752-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  5 in total

1.  Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: a Scandinavian multicenter 'extended pilot study'.

Authors:  Lars Nilsson; Anders Nyboe Andersen; Svend Lindenberg; Jon Hausken; Claus Yding Andersen; Jarl A Kahn
Journal:  Acta Obstet Gynecol Scand       Date:  2010-06       Impact factor: 3.636

Review 2.  Ovarian antral folliculogenesis during the human menstrual cycle: a review.

Authors:  Angela R Baerwald; Gregg P Adams; Roger A Pierson
Journal:  Hum Reprod Update       Date:  2011-11-08       Impact factor: 15.610

3.  GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation.

Authors:  Kutluk Oktay; Ilgın Türkçüoğlu; Kenny A Rodriguez-Wallberg
Journal:  Reprod Biomed Online       Date:  2010-03-06       Impact factor: 3.828

4.  Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation.

Authors:  Shweta R Nayak; Anthony N Wakim
Journal:  Fertil Steril       Date:  2011-05-20       Impact factor: 7.329

5.  Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.

Authors:  Murat Sönmezer; Ilgın Türkçüoğlu; Uğur Coşkun; Kutluk Oktay
Journal:  Fertil Steril       Date:  2011-02-03       Impact factor: 7.329

  5 in total
  14 in total

Review 1.  Ovarian stimulation in the luteal phase: systematic review and meta-analysis.

Authors:  C E Boots; M Meister; A R Cooper; A Hardi; E S Jungheim
Journal:  J Assist Reprod Genet       Date:  2016-05-04       Impact factor: 3.412

2.  Ovarian stimulation protocols for onco-fertility patients.

Authors:  Juliette Koch; William Ledger
Journal:  J Assist Reprod Genet       Date:  2013-02       Impact factor: 3.412

3.  Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve.

Authors:  Chao-Chin Hsu; Isabel Hsu; Li-Hsuan Lee; Yuan-Shuo Hsueh; Chih-Ying Lin; Hui Hua Chang
Journal:  Biomedicines       Date:  2022-06-03

4.  Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies.

Authors:  Jovana Lekovich; Alexandre L S Lobel; Joshua D Stewart; Nigel Pereira; Isaac Kligman; Zev Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2016-03-04       Impact factor: 3.412

5.  Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.

Authors:  Nikita M Shah; Dana M Scott; Pridvi Kandagatla; Molly B Moravek; Erin F Cobain; Monika L Burness; Jacqueline S Jeruss
Journal:  Ann Surg Oncol       Date:  2019-01-24       Impact factor: 5.344

Review 6.  Fertility preservation in women.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Nat Rev Endocrinol       Date:  2013-10-29       Impact factor: 43.330

7.  Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?

Authors:  Giuliano Bedoschi; Volkan Turan; Kutluk Oktay
Journal:  Curr Breast Cancer Rep       Date:  2013-12-01

8.  Random-start GnRH antagonist for emergency fertility preservation: a self-controlled trial.

Authors:  Miguel A Checa; Mario Brassesco; Margalida Sastre; Manuel Gómez; Julio Herrero; Laura Marque; Arturo Brassesco; Juan José Espinós
Journal:  Int J Womens Health       Date:  2015-02-12

9.  Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes.

Authors:  Marie-Madeleine Dolmans; Maria-Laura Marotta; Céline Pirard; Jacques Donnez; Olivier Donnez
Journal:  J Ovarian Res       Date:  2014-08-26       Impact factor: 4.234

Review 10.  GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.

Authors:  Ashraf Alyasin; Shayesteh Mehdinejadiani; Marzieh Ghasemi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.